RIKEN
Center for Brain Science
Education 2009.4-2013.3 Bachelor Degree in Dept. of Life science and Medical Bioscience, School of Advanced Science and engineering, University of Waseda in Japan 2013.4-2015.3 Master’s Degree in Department of Life science and Medical Bioscience, Graduate School of Advanced Science and engineering, Waseda University in Japan 2015.4-2018.3 Doctor’s Degree in Department of Life science and Medical Bioscience, Graduate School of Advanced Science and engineering, Waseda University in Japan (PhD of Science) Academic appointment 2015.4-2018.3 Junior Research Associate in Laboratory for Proteolytic Neuroscience RIKEN Center for Brain Science. 2018.4- Pos-doc in Laboratory for Proteolytic Neuroscience RIKEN Center for Brain Science. 2018.4- Part-time teacher at Teikyo University of Science

Presenter of 1 Presentation

HUMAN MAPT KNOCK-IN MICE THAT HARBOR FAMILIAL TAUOPATHY-CAUSING MUTATIONS

Session Type
SYMPOSIUM
Date
Wed, 16.03.2022
Session Time
08:30 AM - 10:30 AM
Room
ONSITE: 114
Lecture Time
09:15 AM - 09:30 AM

Abstract

Aims

Tauopathy is characterized by accumulation of pathological tau in brain. In order to clarify the disease mechanisms, we aimed to develop mouse models that reproducibly display specific tau pathology without artifacts because the current tauopathy models depend on the overexpression paradigm. The purpose of this study is to develop new tauopathy mouse models by knock-in strategy.

Methods

Previously we generated human MAPT knock-in (hTau-KI) mice, in which the entire Mapt gene was humanized. The hTau-KI mice express all six isoforms (Hashimoto et al.,2019; Saito et al., 2019). In this study, several tauopathy-causing mutations were introduced into hTau-KI mice by Base Editor, a new CRISPR/Cas9-based genome editing technology.

Results

We obtained several tauopathy mouse models (hTau-KI P301L, hTau-KI P301S, hTau-KI P301V, hTau-KI Intron10+3 G>A, hTau-KI P301L; Intron10+3 G>A, hTau-KI P301S; Intron10+3 G>A). Immunohistochemical analyses showed phospho-tau positive signals in the entorhinal cortex and other areas in some of these lines. In addition, biochemical analyses demonstrated that the intronic mutation altered the expression patterns of 3 and 4 repeat tau. Finally, we crossbred these mutant hTau-KI mice with App knock-in mice and found that amyloid pathology accelerated the tau pathology in the brain.

Conclusions

We successfully introduced tauopathy-causing mutations in hTau-KI mice. Consequently, we identified the effects of these MAPT mutations on the pathological and cognitive parameters. We expect these models to contribute to the research community for better understanding the mechanisms of tauopathies.

Hide